Engineers Gate Manager’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $451K | Buy |
+164,773
| New | +$522K | 0.01% | 1462 |
|
|
2025
Q4 | – | Sell |
-102,770
| Closed | -$272K | – | 2222 |
|
|
2025
Q3 | $272K | Buy |
+102,770
| New | +$199K | ﹤0.01% | 1783 |
|
|
2025
Q2 | – | Sell |
-19,131
| Closed | -$27.5K | – | 2260 |
|
|
2025
Q1 | $27.5K | Sell |
19,131
-34,242
| -64% | -$63.1K | ﹤0.01% | 2071 |
|
|
2024
Q4 | $117K | Buy |
53,373
+34,983
| +190% | +$81.6K | ﹤0.01% | 1978 |
|
|
2024
Q3 | $30.3K | Buy |
+18,390
| New | +$37.1K | ﹤0.01% | 2003 |
|
|
2024
Q1 | – | Sell |
-52,932
| Closed | -$158K | – | 2017 |
|
|
2023
Q4 | $158K | Buy |
52,932
+4,541
| +9% | +$5.89K | ﹤0.01% | 1695 |
|
|
2023
Q3 | $47.4K | Sell |
48,391
-24,399
| -34% | -$35.3K | ﹤0.01% | 1657 |
|
|
2023
Q2 | $101K | Buy |
+72,790
| New | +$102K | ﹤0.01% | 1568 |
|
|
2022
Q4 | – | Sell |
-14,596
| Closed | -$98K | – | 1778 |
|
|
2022
Q3 | $98K | Buy |
+14,596
| New | +$100K | 0.01% | 1452 |
|
|
2022
Q1 | – | Sell |
-12,603
| Closed | -$63K | – | 1975 |
|
|
2021
Q4 | $63K | Sell |
12,603
-48,324
| -79% | -$387K | ﹤0.01% | 1851 |
|
|
2021
Q3 | $734K | Buy |
60,927
+23,151
| +61% | +$337K | 0.04% | 664 |
|
|
2021
Q2 | $799K | Buy |
37,776
+4,864
| +15% | +$117K | 0.05% | 533 |
|
|
2021
Q1 | $923K | Buy |
32,912
+199
| +0.6% | +$5.87K | 0.05% | 620 |
|
|
2020
Q4 | $851K | Buy |
+32,713
| New | +$980K | 0.04% | 668 |
|
|
2020
Q3 | – | Sell |
-8,820
| Closed | -$453K | – | 1759 |
|
|
2020
Q2 | $453K | Buy |
+8,820
| New | +$369K | 0.02% | 997 |
|
|
2019
Q3 | – | Sell |
-8,399
| Closed | -$391K | – | 1438 |
|
|
2019
Q2 | $391K | Buy |
+8,399
| New | +$394K | 0.02% | 799 |
|
Other funds holding ESPR
WA
TSC
O
VCM
